Comparative cytocompatibility of commercial theobromine- and fluoride-containing topical varnish extracts in human gingival fibroblast-1 cell
European Journal of Oral Sciences, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Basım Tarihi: 2026
- Doi Numarası: 10.1111/eos.70152
- Dergi Adı: European Journal of Oral Sciences
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE, Academic Search Ultimate (EBSCO), Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest)
- Anahtar Kelimeler: biocompatibility, cytotoxicity, fluoride varnish, human gingival fibroblasts (HGF-1), IC50, LDH release, MTT assay, theobromine, wound healing assay
- Marmara Üniversitesi Adresli: Evet
Özet
Theobromine has been proposed as a non-fluoride remineralizing alternative; however, its cellular biocompatibility in oral cell models remains insufficiently characterized. This study compared the cytocompatibility of a theobromine-containing varnish with two fluoride-containing varnishes in human gingival fibroblast cell line (HGF-1). HGF-1 cells were exposed to extracts prepared from Group 1, Rennou Varnish; Group 2, MI Varnish; and Group 3, Clinpro Clear Fluoride Treatment at concentrations ranging from 0.0625% to 2%. Cell viability and cytotoxicity were evaluated using MTT and lactate dehydrogenase (LDH) assays after 24 h. Cell migration was assessed by wound-healing assay using IC50/2 concentrations. Estimated IC50 values were 0.611% for Group 1, 0.056% for Group 2, and 0.117% for Group 3, with corresponding 95% confidence intervals. Group 1 maintained higher viability and lower LDH release than the fluoride-containing varnishes across most concentrations. Migration was comparable between Groups 1 and 2, whereas Group 3 caused the greatest reduction. These findings should be interpreted as preliminary formulation-level in vitro responses of commercial varnish extracts and should not be attributed to the intrinsic cytocompatibility of any single active ingredient or excipient.